A59522
2-Aminoindan hydrochloride
98%
Sinónimos:
2-Indanamine hydrochloride
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Fórmula empírica (notación de Hill):
C9H11N · HCl
Número de CAS:
Peso molecular:
169.65
Beilstein/REAXYS Number:
3913700
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Productos recomendados
Quality Level
assay
98%
form
crystals
mp
245-247 °C (lit.)
SMILES string
Cl[H].NC1Cc2ccccc2C1
InChI
1S/C9H11N.ClH/c10-9-5-7-3-1-2-4-8(7)6-9;/h1-4,9H,5-6,10H2;1H
InChI key
XEHNLVMHWYPNEQ-UHFFFAOYSA-N
¿Está buscando productos similares? Visita Guía de comparación de productos
Application
Prepared from 2-indanols via azide displacement and subsequent hydrogenation.
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Tetrahedron, 61, 6801-6801 (2005)
Loanda R Cumba et al.
The Analyst, 140(16), 5536-5545 (2015-06-24)
"Synthacaine" is a New Psychoactive Substance which is, due to its inherent psychoactive properties, reported to imitate the effects of cocaine and is therefore consequently branded as "legal cocaine". The only analytical approach reported to date for the sensing of
S X Ma et al.
The Journal of pharmacology and experimental therapeutics, 256(2), 751-756 (1991-02-01)
Dopaminergic structure-activity relationships of 2-aminoindans were evaluated for their ability to inhibit responses to stimulation of cardioaccelerator nerves in cats. The major observations were as follows: 1) Unsubstituted di-n-propyl- and diethyl 2-aminoindan derivatives do not inhibit responses to stimulation of
J G Cannon et al.
Journal of medicinal chemistry, 29(10), 2016-2020 (1986-10-01)
The ortho hydroxy/methyl, hydroxy/hydroxymethyl, hydroxy/formyl, and hydroxy/carboxy substitution patterns, some of which confer dopaminergic agonist effects upon 2-aminotetralin ring systems, have been incorporated into beta-phenethylamine, 2-aminoindan, and trans-octahydrobenzo[f]quinoline rings. Certain of the 2-aminoindan derivatives displayed pharmacologic properties consistent with their
W Dimpfel et al.
BMC pharmacology, 11, 2-2 (2011-02-23)
Rasagiline, a new drug developed to treat Parkinson's disease, is known to inhibit monoamine oxidase B. However, its metabolite R-(-)-aminoindan does not show this kind of activity. The present series of in vitro experiments using the rat hippocampal slice preparation
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico